Archive for the 'Pharma' Category
Here’s some of links to articles about the growth of MRSA and other antibiotic-resistant bacteria. Quite a lot of interest in this given the recent paper by Dr. Monina Klevens et al at the CDC which concluded:
“Based on 8,987 observed cases of MRSA and 1,598 in-hospital deaths among patients with MRSA, we estimate that 94,360 [...]
As a follow up to my two pieces about the strange attraction between discussion of the Thai government’s origins in a military coup and any mention of the compulsory licensing program, I would suggest reading this post that dissects some of the dis-information campaign re: the Thai compulsory licensing program over at the blog Pheripheries.
Well it appears that the Financial Times is not alone in mentioning that the Thai government is not a democracy every time they discuss the mandatory licensing issue. It seems as if there might be a co-ordinated talking point memo out there somewhere, no?
Tariffs the real barrier to HIV treatment
By Tim Wilson
The close [...]
Well, as expected, another country has joined Thailand in threatening to “break the patent” for Merck’s Efavirenz. Bloomberg has some reporting of the dispute, and it’s filled with sideways adjectives describing the dispute in a quite stilted way. But this is to be expected, after all someone is trying to buck the patent [...]
If an important story concerning an issue of manifest public concern shows up in the New York Times only five years after its been written about in many well-researched books, is it still really a newspaper? Don’t we maybe need another word? What about all those images in the popular culture of newspapers rushing [...]
Well, it appears that Indonesia is wondering why it should continue it’s efforts obtaining, identifying, processing and purifying bird flu samples, if WHO is going to give them to just a few Western big pharmaceutical concerns, so those concerns can in turn patent the resulting vaccines, and later extract monopoly prices, and in the process [...]
A Process that (very strangely) is under the radar of most right now is the expansion of the Not-for-Profit Sector into fields that were traditionally the exclusive reserve of the for profits. There was an interesting article in The McKinsey Quarterly* a while back that caught my attention with some facts about the Not-for-Profit [...]
Well here we have real irresponsibility, and it’s just one of many examples of the USA health infrastructure falling to sub-standard oversight. In typical fashion, this has received almost no press coverage, and caters to the interests of the pharmaceutical industry and the mega-food manufacturers, ignoring the advice of the American Medical Association and [...]
Updates of 28 October 2007 are italicized
Well here we have real irresponsibility, and it’s just one of many examples of the USA health infrastructure falling to sub-standard oversight. In typical fashion, this has received almost no press coverage, and caters to the interests of the pharmaceutical industry and the mega-food manufacturers, ignoring the [...]
A modest post, including, as a special bonus, an enlightened understanding of the terms amazingly free and military-installed…
Here we have a story about a developing country, realizing that it can’t afford some of the most expensive medicines, announcing that it will therefore begin producing generic versions of these very few very expensive medications. This is [...]
-
Recent Comments
